Comprehensive assessment of novel cardiovascular biomarkers in AF
Amelie H Ohlrogge, Daniel Engler, Patricia Schlieker, Ferdinand Seum, Kim Rosebrock, Nicole Nebel, Dora Csengeri, Larissa Fabritz, André Ziegler, Stefan Blankenberg, Paulus Kirchhof, Tanja Zeller, Renate B Schnabel · 2026
Read Comprehensive assessment of novel cardiovascular biomarkers in AF by Amelie H Ohlrogge, Daniel Engler, Patricia Schlieker, Ferdinand Seum, Kim Rosebrock, Nicole Nebel, Dora Csengeri, Larissa Fabritz, André Ziegler, Stefan Blankenberg, Paulus Kirchhof, Tanja Zeller, Renate B Schnabel (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13199998.txt.
Description
Amelie Ohlrogge and eleven co-authors test four new blood markers against the standard one in atrial fibrillation, in a paper dated 2026. The standard marker, a heart-stretch peptide, already predicts trouble. The newcomers report on vessel growth, heart development signals, and cell stress, and might foresee strokes, heart failure, or death earlier.
The cohort held over a thousand people, half with the rhythm disorder and half at risk, followed for a median of forty-two months. All five markers were measured with high-precision assays. The combined outcome counted strokes, heart attacks, new heart disease, heart failure, and death, which struck about a fifth of participants. Head-to-head marker data across the disease course helps clinics decide whether the newer tests earn a place beside the standard.
Catalog record
| CREATOR | Amelie H Ohlrogge, Daniel Engler, Patricia Schlieker, Ferdinand Seum, Kim Rosebrock, Nicole Nebel, Dora Csengeri, Larissa Fabritz, André Ziegler, Stefan Blankenberg, Paulus Kirchhof, Tanja Zeller, Renate B Schnabel |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |